Anti-3-[ <sup>18</sup> F]FACBC Positron Emission Tomography-Computerized Tomography and <sup>111</sup> In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma: Results of a Prospective Clinical Trial - Concepedia

Concepedia

Publication | Open Access

Anti-3-[ <sup>18</sup> F]FACBC Positron Emission Tomography-Computerized Tomography and <sup>111</sup> In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prostate Carcinoma: Results of a Prospective Clinical Trial

DOI Full Paper Access

171

Citations

22

References

2013

Year

David M. Schuster, Peter T. Nieh, Ashesh B. Jani, Rianot Amzat, F. DuBois Bowman, Raghuveer Halkar, Viraj A. Master, Jonathon A. Nye, Oluwaseun Odewole, Adeboye O. Osunkoya,

The Journal of Urology

Abstract

Better diagnostic performance was noted for anti-3-[(18)F]FACBC positron emission tomography-computerized tomography than for (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for prostate carcinoma recurrence. The former method detected significantly more prostatic and extraprostatic disease.

References

	Year	Citations

Page 1